The document reviews in vitro methods for evaluating antidiabetic activities of drugs, detailing assays for α-amylase and α-glucosidase inhibition, along with in vivo glucose absorption studies. It discusses procedures for measuring enzyme activity and the impact of inhibitors on glucose levels in model organisms. The findings contribute to understanding the mechanisms of action for antidiabetic agents and highlight various experimental approaches in drug assessment.